spiriva respimat 2.5 mikrog
boehringer ingelheim international gmbh - tiotropiumbromid - inhalasjonsvæske, oppløsning - 2.5 mikrog
roflumilast accord 500 mikrog
accord healthcare b.v. - roflumilast - tablett, filmdrasjert - 500 mikrog
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.